Is NCT07225075 recruiting in Springfield, MA?

Yes, NCT07225075 is currently recruiting participants at its Springfield, MA location. This intracranial aneurysm clinical trial is actively enrolling qualified participants.

How do I join the intracranial aneurysm clinical trial in Springfield?

To join this clinical trial in Springfield, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Springfield clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Intracranial Aneurysm Clinical Trial in Springfield, MA

Who Can Participate

Inclusion Criteria

Age 22 to ≤ 80 years old

Participant has a single target unruptured intracranial aneurysm (IA) originating from a parent vessel of 1.5 mm to 3.4mm in diameter located at or distal to the ICA terminus or in SVB-amenable anterior or posterior anatomy

Participant has a target saccular or fusiform IA with an aneurysm neck ≥ 4mm or a dome to neck ratio \<2

Participant has a target IA that is ≤ 12 mm

Participant meets one or more risk factors for IA rupture, such as age (≤70); hypertension; cigarette smoking; use of sympathomimetic drugs; Japanese or Finnish ancestry; history of prior aneurysmal subarachnoid hemorrhage (aSAH); familial intracranial aneurysms or SAH; clinical or radiological mass effect; reduced quality of life due to fear of rupture; IA size, location, and morphology (yielding 1 point or greater score per UIATS scale); documented growth of IA on serial imaging; presence of multiple IAs; and presence of concurrent pathology

Participant has pre-procedure (obtained up to 14 days prior to the procedure day) PRU value between 60-200

Participant or a legally authorized representative (LAR) provides written informed consent using the IRB/REB-approved consent form and agrees to comply with protocol follow-up and requirements

Exclusion Criteria

Target aneurysm is unsuitable for flow diverter treatment

Subject requires more than one flow diverter for target aneurysm treatment

Has vessel characteristics, such as severe tortuosity, stenosis, atherosclerotic disease, or morphology that would preclude safe endovascular access to the target aneurysm necessary for treatment with the study device

Received previous treatment of the target aneurysm or parent artery where it would interfere with the placement or proper apposition of the device

Has a medical contraindication to study or procedure-related antiplatelet/anticoagulation medications (e.g., aspirin, clopidogrel/Plavix, ticagrelor, Prasugrel, Gp IIb/IIIa inhibitors, heparin, etc.), local or general anesthesia, or life-threatening allergy to contrast dye

Has a known severe allergy to nickel, titanium or platinum

Modified Rankin Score (mRS) assessment is ≥ 3 at screening or pre-procedure mRS could not be assessed

The health of the participant or the validity of the study outcomes (e.g., high risk of neurologic events, worsening of clinical condition in the last 30 days) may be compromised by the participant's enrollment

Subarachnoid hemorrhage occurred within 30 days prior to enrollment

Intracranial parenchymal hemorrhage occurred within 60 days prior to enrollment

Major surgery (including previous intracranial implant) occurred within previous 30 days or is planned in the next 120 days after treatment date

Has more than one IA that requires treatment within 120 days of treatment date

Received previous intracranial implant associated with the symptomatic or vascular distribution within the past 12 weeks prior to treatment date

Requires adjunctive coiling during SVB procedure

Chronic anticoagulation therapy is ongoing or known coagulopathy exists

Has other known serious concurrent medical conditions such as active bacterial infection, heart disease (including atrial fibrillation, pacemaker, recent myocardial infarction \[\< 12 weeks\], symptomatic congestive heart failure, or carotid stenosis), kidney failure (e.g., \>2.0mg/dl serum creatinine) or any other non-neurological disease-related acute life threatening illness to be treated in this trial, pulmonary disease, uncontrolled diabetes, progressive neurologic disorders, cancer requiring active treatment (e.g., chemotherapy, etc.) or on palliative care, vasculitis, high risk of ischemic stroke or recent stroke (within 30 days)

Life expectancy is less than 5 years due to other illness or condition (in addition to an intracranial aneurysm)

Unable to complete study follow-up due to dementia or psychiatric disorder, substance abuse, or history of noncompliance with medical advice

Women who are pregnant or nursing at the time of enrollment or women who wish to become pregnant during the length of study participation

Presence of intracranial mass (tumor, except meningioma that doesn't require surgery for 1 year) or non-treated arteriovenous malformation (AVM) in the territory of the target aneurysm

Participation in any other investigational study which can influence collection of valid data under this study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Springfield?

Yes, this clinical trial (NCT07225075) has an active research site in Springfield, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Intracranial Aneurysm Treatment Options in Springfield, MA

If you're searching for intracranial aneurysm treatment options in Springfield, MA, this clinical trial (NCT07225075) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Springfield research site is actively enrolling participants for this clinical trial. You'll receive care from experienced intracranial aneurysm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all intracranial aneurysm clinical trials near you to find additional studies recruiting in your area.

Intracranial Aneurysm Clinical Trial in Springfield, MA

Expert Care in Springfield

IRB Approved

No-Cost Care

Apply for This Springfield Location

Why Participate?

Simple Process

About This Intracranial Aneurysm Study in Springfield